GSK256066 2,2,2-trifluoroacetic acid - CAS 1415560-64-3
Catalog number:
1415560-64-3
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C29H27F3N4O7S
Molecular Weight:
632.61
COA:
Inquire
Targets:
PDE4
Description:
GSK256066 is a selective PDE4B(equal affinity to isoforms A-D) inhibitor with IC50 of 3.2 pM, >380,000-fold selectivity versus PDE1/2/3/5/6 and >2500-fold selectivity against PDE4B versus PDE7.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Synonyms:
GSK-256066; GSK 256066
MSDS:
Inquire
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related PDE4 Products


AN3199
(CAS: 1187187-10-5)

AN3199, a PDE4 inhibitor, was once studied as an anti-inflammatory agent. IC50: 94.5 nM

CAS 1415560-64-3 GSK256066 2,2,2-trifluoroacetic acid

GSK256066 2,2,2-trifluoroacetic acid
(CAS: 1415560-64-3)

GSK256066 is a selective PDE4B(equal affinity to isoforms A-D) inhibitor with IC50 of 3.2 pM, >380,000-fold selectivity versus PDE1/2/3/5/6 and >2500-fold...

MK0873
(CAS: 500355-52-2)

MK0873 is a phosphodiesterase 4 (PDE4) inhibitor. It has shown as an innovative tool to design topical formulation to achieve desired pharmacokinetics in humans...

CAS 101975-10-4 Zardaverine

Zardaverine
(CAS: 101975-10-4)

Zardaverine is a newly developed dual-selective PDE3/4 inhibitor with IC50 values of 0.5 μM and 0.8 μM respectively.

CI-1044
(CAS: 197894-84-1)

CI-1044, a selective PDE4 inhibitor, inhibits in vitro LPS-induced TNF-alpha release in whole blood from COPD patients better than rolipram and cilomilast and s...

CAS 418794-42-0 Ronomilast

Ronomilast
(CAS: 418794-42-0)

Ronomilast is type 4 cyclic nucleotide phosphodiesterase inhibitor for the treatment of chronic obstructive pulmonary disease (COPD).

CP-220629
(CAS: 162141-96-0)

CP-220629, a Pyrazolopyridin derivative, has been found to be a Type 4 cyclic nucleotide phosphodiesterase inhibitor that was once studied as an anti-inflammato...

CAS 153259-65-5 Cilomilast

Cilomilast
(CAS: 153259-65-5)

Selective phosphodiesterase 4 (PDE4) inhibitor. Antiasthmatic; used in treatment of chronic obstructive pulmonary disease.

CAS 162401-32-3 Roflumilast

Roflumilast
(CAS: 162401-32-3)

Roflumilast has antiinflammatory effects and is under development as an orally administered drug for the treatment of inflammatory conditions of the lungs such ...

GSK-356278
(CAS: 720704-34-7)

GSK-356278 is a selective Type 4 cyclic nucleotide phosphodiesterase inhibitor. It shows anxiolytic and cognition-enhancing effects and it has the ability to el...

CAS 346629-30-9 MK-0359

MK-0359
(CAS: 346629-30-9)

MK-0359 is a selective and potent oral PDE4 inhibitor with in vivoefficacy in animal models of asthma and cognition.

CAS 801312-28-7 GSK256066

GSK256066
(CAS: 801312-28-7)

GSK256066 is a selective PDE4B(equal affinity to isoforms A-D) inhibitor with IC50 of 3.2 pM, >380,000-fold selectivity versus PDE1/2/3/5/6 and >2500-fold selec...

CAS 85416-73-5 S- (+)-Rolipram

S- (+)-Rolipram
(CAS: 85416-73-5)

S-(+)-Rolipram inhibits human monocyte cyclic AMP-specific PDE4 with IC50 of 0.75 μM, has anti-inflammatory and anti-depressant activity in the central nervous ...

CAS 778576-62-8 Oglemilast

Oglemilast
(CAS: 778576-62-8)

Oglemilast is a potent PDE4 inhibitor and under clinical studies in the treatment of allergen-induced asthma.

CAS 61413-54-5 Rolipram

Rolipram
(CAS: 61413-54-5)

Rolipram is a selective PDE4-inhibitor and an anti-inflammatory agent.

CAS 166741-91-9 Tilivapram

Tilivapram
(CAS: 166741-91-9)

Tilivapram, a pyridine derivative, has been found to be a phosphodiesterase IV inhibitor that could probably be used in studying its bioactivities in sorts of a...

CAS 608141-41-9 Apremilast

Apremilast
(CAS: 608141-41-9)

Apremilast (CC-10004)is an orally available small molecule inhibitor of phosphodiesterase 4 (PDE4). Apremilast specifically inhibits PDE4 and inhibits spontaneo...

NVP-ABE-171
(CAS: 426268-06-6)

NVP-ABE171 is a potent and novel phosphodiesterase 4 inhibitor with anti-inflammatory activities inhibited the activity of phosphodiesterase 4A, 4B, 4C, and 4D ...

CP-671305
(CAS: 445295-04-5)

CP-671305 is a potent and selective inhibitor of PDE4.

CAS 906673-24-3 crisaborole

crisaborole
(CAS: 906673-24-3)

Crisaborole is a novel PDE-4 inhibitor used as a nonsteroidal topical medication for the treatment of mild-to-moderate atopic dermatitis (eczema). Crisaborole s...

Chemical Structure

CAS 1415560-64-3 GSK256066 2,2,2-trifluoroacetic acid

Quick Inquiry

Verification code

Featured Items